029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FUR1021子宫内膜癌组织芯片，附病理分级、TNM和临床分期，102例/102点
点 数102例 数102
行 数8列 数13
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FUR1021
 
子宫内膜癌组织微阵列芯片，包含90例子宫内膜样腺癌，3例粘液腺癌，4例腺鳞癌，2例肉瘤样癌，3例子宫内膜，一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
*
-*
Ute
-Uterus
 
* (*)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIC1)
 
NAT (*)
 
Normal (*)
TISSUE  ARRAYS FUR1021
1
2
3
4
5
6
7
8
9
10
11
12
13
A
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
B
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
C
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
D
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
E
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
F
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
G
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
*
H
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
*
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1135FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant*N
A2257FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A3357FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
A4438FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
A5549FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant5*5N
A6647FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant9*9N
A7756FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant3*2.5*1.2N
A8853FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant6*4*4N
A9954FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*2*0.5N
A101050FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant11*10*4N
A111137FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant6*4.5*3N
A121253FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant9*8*8N
A131368FUterusEndometrioid adenocarcinoma with necrosis1T1bN0M0IBMalignant7*4*4N
B11443FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant8*7*6N
B21549FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*1N
B31643FUterusEndometrioid adenocarcinoma with necrosis1T1aN0M0IAMalignant2*2N
B41753FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant9*9*4N
B51837FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant4*3*1.5N
B61963FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
B72051FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
B82140FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
B92270FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
B102333FUterusEndometrioid adenocarcinoma1--2T1bN0M0IBMalignant11*9*4N
B112456FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3.5N
B122550FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*4*0.5N
B132652FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
C12770FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
C22850FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C32943FUterusEndometrioid adenocarcinoma with necrosis2T2N0M0IIMalignant*N
C43052FUterusEndometrioid adenocarcinoma with degenerate2T1bN0M0IBMalignant*N
C53145FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C63256FUterusEndometrioid adenocarcinoma2T3N1M0IIIC1Malignant*N
C73358FUterusEndometrioid adenocarcinoma with necrosis2T2N1M0IIIC1Malignant*N
C83443FUterusEndometrioid adenocarcinoma2T2N1M0IIIC1Malignant*N
C93561FUterusEndometrioid adenocarcinoma with necrosis2T2N0M0IIMalignant3*2N
C103630FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C113757FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C123852FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
C133958FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D14046FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D24174FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*3*2N
D34254FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant2.5*2*1N
D44356FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant6*4.5*1.5N
D54470FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant1.5*4.5*2N
D64552FUterusEndometrioid adenocarcinoma with necrosis2T1bN0M0IBMalignant4*3*2N
D74668FUterusEndometrioid adenocarcinoma with necrosis2T3aN0M0IIIAMalignant8*6*4N
D84754FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant9*5*3N
D94850FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant6*4*2.5N
D104958FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3*3N
D115043FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant7*3*3N
D125179FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4*3*0.8N
D135256FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
E15355FUterusEndometrioid adenocarcinoma (interstitial)*T2N0M0IIMalignant*N
E25454FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant6.0*4.0*1.5N
E35553FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant5.0*3.0*1.0N
E45646FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.0*2.5*0.5N
E55752FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4.0*4.0*0.8N
E65852FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant4.0*3.5*0.5N
E75950FUterusEndometrioid adenocarcinoma with necrosis2--3T2N0M0IIMalignant6.0*4.5*1.0N
E86052FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant5.0*4.5*1.0N
E96153FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant*N
E106263FUterusEndometrioid adenocarcinoma (sparse)2--3T3aN0M0IIIAMalignant9*3*2.5N
E116358FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant10*9*7N
E126452FUterusEndometrioid adenocarcinoma2--3T1bN1M0IIIC1Malignant*N
E136543FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant*N
F16648FUterusEndometrioid adenocarcinoma with squamous differentiation2--3T1aN0M0IAMalignant*N
F26742FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant3*2.5*1N
F36851FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant*N
F46958FUterusEndometrioid adenocarcinoma with necrosis3T3N1M0IIIC1Malignant3*2N
F57045FUterusEndometrioid adenocarcinoma3T1bN1M0IIIC1Malignant*N
F67154FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant6*4.5*1N
F77250FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant*N
F87354FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant6*4.5*1N
F97442FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant3.5*3.0*1N
F107548FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
F117638FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant5*4*3N
F127764FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*4N
F137862FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3*2*1N
G17949FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant5*5*4N
G28053FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant7*6*4N
G38160FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*3*2.5N
G48251FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant8*4.5*4.5N
G58351FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant4*3N
G68453FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant4*2.5*1.5N
G78562FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*1.2N
G88643FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant3.5*3*2.5N
G98766FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant*N
G108863FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
G118955FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
G129052FUterusEndometrioid adenocarcinoma with degenerate3T2bN0M0IIBMalignant*N
G1391***blank*****N
H19242FUterusMucinous adenocarcinoma1T2N0M0IIMalignant*N
H29346FUterusMucinous adenocarcinoma2T3aN0M0IIIAMalignant*N
H39448FUterusMucinous adenocarcinoma2T2bN0M0IIBMalignant*N
H49552FUterusAdenosquamous carcinoma3T1bN0M0IBMalignant*N
H59669FUterusAdenosquamous carcinoma3T1bN0M0IBMalignant*N
H69763FUterusAdenosquamous carcinoma3T1cN1M0IIIC1Malignant*N
H79845FUterusAdenosquamous carcinoma3T1bN0M0IBMalignant*N
H89953FUterusSarcomatoid carcinoma*T2N0M0IIMalignant*N
H910052FUterusSarcomatoid carcinoma*T2N0M0IIMalignant*N
H1010152FUterusEndometrial tissue***NAT*N
H1110246FUterusEndometrial tissue***NAT*N
H1210354FUterusEndometrial tissue***Normal*N
H13104***blank****N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情